Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
- DOI
- 10.1016/j.ejca.2017.01.033
- Published
- 2017 May
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2017.01.033,
title = {Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.},
author = {Zschäbitz S and Lasitschka F and Hadaschik B and Hofheinz RD and Jentsch-Ullrich K and Grüner M and Jäger D and Grüllich C},
year = {2017},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/j.ejca.2017.01.033},
url = {https://doi.org/10.1016/j.ejca.2017.01.033}
}RIS
TY - JOUR TI - Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation. AU - Zschäbitz S AU - Lasitschka F AU - Hadaschik B AU - Hofheinz RD AU - Jentsch-Ullrich K AU - Grüner M AU - Jäger D AU - Grüllich C PY - 2017 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/j.ejca.2017.01.033 UR - https://doi.org/10.1016/j.ejca.2017.01.033 ER -
APA
S, Z., F, L., B, H., RD, H., K, J., M, G., D, J., & C, G. (2017). Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2017.01.033
Source records
- pubmed · retrieved 2026-09-26T15:05:41.633Z
- europe-pmc · retrieved 2026-09-26T15:05:41.630Z